No definition available.
Kaposi sarcoma, excluding all cancers (controls excluding all cancers)
C3_KAPOSI_SARCOMA_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
61 |
4. Check minimum number of eventsNone |
61 |
5. Include endpointsNone |
61 |
6. Filter based on genotype QC (FinnGen only) |
61 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- C45-C49
- Name in latin
- Sarcoma Kaposi
Similar endpoints
↥List of similar endpoints to
Kaposi sarcoma, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Kaposi sarcoma
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 61 | 16 | 45 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 72.97 | 66.89 | 75.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 52
- Matched controls
- 519
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C46.0
ICD-10 Finland
Kaposi sarcoma of skin
+∞
39.7
33
*
9140/3-C44.7
ICD-O-3
Kaposi sarcoma of skin of lower limb and hip
+∞
18.8
17
*
C46.9
ICD-10 Finland
Kaposi sarcoma, unspecified
+∞
11.9
11
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
27.1
8.4
11
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
7.4
7
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
10.1
7.2
14
18
ZZA00
NOMESCO Finland
Split skin graft
46.0
6.9
8
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
15.0
6.4
10
8
C46.7
ICD-10 Finland
Kaposi sarcoma of other sites
+∞
6.4
6
*
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
6.4
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.4
6
*
C46.3
ICD-10 Finland
Kaposi sarcoma of lymph nodes
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
16
9
23.47
11.47
2.1
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
32
7.56
10.46
1.7
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
19
7.62
7.55
4.6
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
29
104
4.41
7.49
3.9
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
14
27
6.43
7.37
2.4
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
14
8.35
6.92
4.7
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
16
46
4.36
5.32
1.8
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
7
8
9.68
3.88
1.6
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
34
189
2.81
3.79
12.4
3.1
umol/l
9.9
13.1
1.61
34
178
(3044640) Blood type and Crossmatch panel - Blood
23
107
2.85
3.55
5.1
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
8
14
6.39
3.47
9.1
2.3
g/l
0.4
0.2
—
8
6
(42870588) Differential panel, method unspecified - Blood
24
117
2.73
3.37
11.0
4.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
12
39
3.59
3.30
2.4
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
17
5.24
3.03
1.6
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
17
5.24
3.03
3.7
1.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
29
164
2.46
2.94
14.4
5.1
%
58.0
59.4
0.26
29
147
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
6
8.93
2.80
4.2
5.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
13
51
2.97
2.65
2.4
1.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
12
47
2.93
2.44
2.8
2.7
g/l
2.3
2.2
0.12
12
42
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
24
134
2.30
2.42
3.8
3.1
—
—
—
0
0
(3015736) pH of Urine
25
143
2.27
2.37
4.8
3.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
13
4.99
2.33
1.7
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
6
13
4.99
2.33
5.7
1.7
ug/l
0.5
0.7
—
6
8
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
25
146
2.21
2.24
8.8
3.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
13
56
2.68
2.23
2.8
2.5
umol/l
11.5
12.1
0.08
13
51
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
8
25
3.52
2.18
2.5
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
37
255
2.15
2.15
6.2
4.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
16
78
2.43
2.15
15.7
3.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
15
4.31
2.09
4.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
11
45
2.76
2.06
4.3
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7
21
3.62
2.03
1.4
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
18
95
2.27
2.02
4.4
2.6
umol/l
361.3
5267.1
0.50
18
84
(3021601) Nitrite [Presence] in Urine by Test strip
28
179
2.04
1.94
7.2
4.7
estimate
0.0
0.0
—
5
32
(3030981) Hyaline casts [#/volume] in Urine by Automated count
7
23
3.30
1.86
5.6
3.7
e6/l
0.1
0.2
—
7
23
(3020630) Protein [Mass/volume] in Serum or Plasma
7
23
3.30
1.86
1.6
1.7
g/l
60.6
65.2
—
7
17
(3035350) Ketones [Presence] in Urine by Test strip
27
175
1.97
1.76
5.1
3.5
estimate
0.0
0.0
—
6
32
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
14
70
2.30
1.76
2.9
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
28
184
1.96
1.76
5.2
3.6
estimate
0.0
0.0
—
6
31
(3008037) Lactate [Moles/volume] in Venous blood
5
13
4.09
1.75
4.6
1.9
mmol/l
1.4
1.3
—
5
13
(3038515) Glucose [Moles/volume] in Venous blood
5
13
4.09
1.75
4.6
1.9
mmol/l
10.4
6.9
—
5
13
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
13
66
2.23
1.57
2.3
2.5
e6/l
1.5
0.7
—
7
35
(3021589) Normoblasts [#/volume] in Blood
24
155
1.90
1.55
17.8
8.3
e9/l
0.0
0.0
0.48
19
125
(40768797) Stomach Pathology biopsy report
10
46
2.40
1.49
1.1
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
22
2.91
1.47
1.0
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
16
3.31
1.47
5.8
3.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
68
2.16
1.47
3.1
2.7
e6/l
1.4
1.5
—
7
37
(40760892) CBC W Ordered Manual Differential panel - Blood
11
55
2.22
1.37
15.0
4.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
6
24
2.66
1.34
3.2
5.8
ng/l
71.5
99.2
—
6
19
(3023368) Bacteria identified in Blood by Culture
19
119
1.87
1.32
5.5
4.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
25
171
1.78
1.31
35.8
11.6
inr
1.8
1.5
—
6
55
(36304419) Bacteria [Presence] in Urine
17
104
1.88
1.26
2.3
2.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
16
96
1.90
1.26
1.7
1.8
mmol/l
1.4
1.3
0.25
16
81
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
5
19
2.77
1.24
3.6
2.0
%
1.8
1.5
—
5
19
(3007930) Methemoglobin/Hemoglobin.total in Blood
5
19
2.77
1.24
3.6
2.0
%
0.6
0.9
—
5
19
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
7
35
2.13
1.04
1.4
1.4
u/l
33.6
27.1
—
7
29
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
11
62
1.94
1.02
2.1
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
23
164
1.65
1.00
1.7
2.0
pmol/l
86.0
83.3
0.12
17
78
(40761536) Microorganisms panel - Urine sediment
6
30
2.11
0.89
4.0
3.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
15
98
1.70
0.89
4.3
3.7
estimate
0.0
0.0
—
5
30
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
6
31
2.03
0.87
5.3
2.4
mmol/l
1.2
2.0
—
6
23
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
43
366
1.59
0.84
25.6
13.1
ml/min/173m2
76.4
72.2
0.46
34
292
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
32
1.97
0.84
1.8
7.1
g/l
108.0
121.2
—
6
32
(3022145) Colonoscopy Study observation
6
33
1.91
0.81
1.5
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
0
24
0.00
0.81
0.0
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
23
2.27
0.78
6.0
2.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
5
23
2.27
0.78
4.6
2.3
g/l
131.6
128.5
—
5
23
(3041096) Erythrocytes [Presence] in Urine by Automated
16
111
1.60
0.76
6.1
3.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
40
1.85
0.74
1.4
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
41
1.80
0.73
1.1
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
5
26
2.00
0.72
1.0
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
29
1.79
0.65
2.2
3.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
11
72
1.64
0.64
3.6
3.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
8
51
1.65
0.63
6.8
1.9
mmol/l
0.7
0.8
—
8
46
(3013512) EKG study
18
134
1.49
0.62
8.4
4.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
19
144
1.46
0.60
5.4
3.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
6
40
1.55
0.53
4.3
3.9
mmol/l
2.9
2.5
—
6
29
(3012544) pH of Venous blood
6
40
1.55
0.53
4.3
4.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
46
417
1.42
0.49
34.4
16.0
umol/l
83.3
88.6
0.68
46
417
(1761868) Lipid panel - Serum or Plasma
16
124
1.39
0.44
3.3
3.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
44
400
1.36
0.43
32.4
13.3
mg/l
23.9
25.0
0.10
38
311
(3019225) pH of Specimen
6
42
1.47
0.37
7.8
3.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
15
119
1.35
0.36
1.9
1.7
u/l
52.1
57.6
0.17
15
111
(3003694) ABO and Rh group [Type] in Blood
11
83
1.40
0.35
1.3
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
6
46
1.34
0.34
1.8
6.3
kpa
4.8
4.9
—
6
41
(3027801) Oxygen [Partial pressure] in Arterial blood
6
46
1.34
0.34
1.8
6.3
kpa
10.4
9.6
—
6
41
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
23
197
1.27
0.32
2.1
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
5
71
0.68
0.28
16.4
28.7
—
1.4
—
0
9
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
9
71
1.31
0.27
1.1
1.2
—
1.0
—
0
19
(3000963) Hemoglobin [Mass/volume] in Blood
47
442
1.28
0.27
43.4
18.9
g/l
131.6
137.4
1.27
47
427
(3019550) Sodium [Moles/volume] in Serum or Plasma
44
411
1.25
0.27
31.4
17.0
mmol/l
139.0
139.8
1.22
44
393
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
5
38
1.34
0.24
2.8
1.4
%
1.4
1.8
—
5
32
(3026008) Bacteria identified in Urine by Culture
14
117
1.26
0.23
4.6
3.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
44
415
1.22
0.22
31.5
16.9
mmol/l
4.0
4.0
0.06
44
397
(3039443) Prostate specific Ag panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(4094501)
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
14
122
1.19
0.15
3.1
2.7
ug/l
0.7
0.8
—
9
77
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
19
171
1.16
0.15
5.9
3.5
%
18.0
25.6
—
6
72
(3003338) MCHC [Mass/volume]
35
330
1.14
0.14
39.2
16.5
g/l
332.0
332.7
0.13
35
325
(3035941) MCH [Entitic mass]
46
442
1.17
0.14
43.9
18.8
pg
30.7
30.4
0.47
46
426
(3024731) MCV [Entitic volume]
46
442
1.17
0.14
44.0
18.7
fl
92.2
91.2
0.75
46
426
(3044889) 12 lead EKG panel
30
282
1.13
0.12
4.8
4.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
40
387
1.10
0.07
13.7
5.1
mmol/l
6.1
6.2
0.11
35
341
(3012516) Albumin [Mass/volume] in Urine
15
139
1.10
0.06
3.7
3.2
mg/l
198.8
542.7
—
9
86
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
15
139
1.10
0.06
2.3
2.3
u/l
150.5
211.0
0.53
15
130
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
28
269
1.08
0.05
4.1
3.3
pmol/l
15.7
14.8
0.75
23
232
(40761511) CBC panel - Blood by Automated count
40
410
0.93
0.04
27.7
12.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
35
343
1.05
0.01
27.5
13.8
%
38.3
40.6
0.37
22
229
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
7
0.00
0.00
0.0
3.0
—
68.0
—
0
7
(3024928) Oxygen saturation in Venous blood
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_KAPOSI_SARCOMA_EXALLC – Kaposi sarcoma, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).